Trial intelligence / Profile preview

STI and IL-2 in Primary HIV Infection

NCT02300623Phase 4Completed

Start
Mar 2000
Primary completion
Apr 2013
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 4 trial of aldesleukin in human immunodeficiency virus infection (HIV). Started Mar 2000; status: completed.

02

Drugs

aldesleukin
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT02300623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02300623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call